Zenas biopharma to present at the guggenheim smid cap biotech conference

Waltham, mass., jan. 28, 2025 (globe newswire) -- zenas biopharma, inc. (“zenas” or the “company”) (nasdaq: zbio), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced management's fireside chat presentation at the guggenheim smid cap biotech conference on wednesday, february 5, 2025, at 3:00 p.m. et.
SMID Ratings Summary
SMID Quant Ranking